AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 290: H2051-H2058, 2006. First published December 30, 2005; doi:10.1152/ajpheart.01040.2005
0363-6135/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/5/H2051    most recent
01040.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jacobi, J.
Right arrow Articles by Kristal, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacobi, J.
Right arrow Articles by Kristal, B.

Priming of polymorphonuclear leukocytes: a culprit in the initiation of endothelial cell injury

Jeanna Jacobi,1 Shifra Sela,1,5 Hector I. Cohen,2 Judith Chezar,3 and Batya Kristal4,5

1Eliachar Research Laboratory, 2Pathology Laboratory, 3Hematology Laboratory, and 4Department of Nephrology and Hypertension, Western Galilee Hospital, Nahariya, and 5Bruce Rappoport School of Medicine, Technion, Haifa, Israel

Submitted 3 October 2005 ; accepted in final form 23 December 2005

Peripheral polymorphonuclear leukocytes (PMNL) in hemodialysis (HD) patients are primed, continually releasing and exposing the vascular endothelium to soluble factors such as reactive oxygen species and inflammatory mediators. To mimic the close proximity between PMNL and the endothelial monolayer and to monitor and characterize the influence of soluble mediators released from PMNL, we developed a novel cocultivation system using primary human umbilical vein endothelial cell (HUVEC) cultures and PMNL, with a sieve separating the two cell types to prevent direct adhesive effects. PMNL (106) from HD patients or from healthy normal controls were cocultivated with HUVEC (105) for 15 min, and endothelial cell injury was assessed by HUVEC morphology, cell detachment, and apoptosis. Proinflammatory changes were estimated by expression of HUVEC adhesion molecule P-selectin and by endothelial IL-8 and endothelial nitric oxide synthase mRNA. The levels of intracellular tissue factor reflected the procoagulant state, whereas NADPH oxidase activity served as an indicator for prooxidative changes in HUVEC. Mediators released from the primed PMNL triggered activation/dysfunction of endothelial cells, causing 1) an increase in endothelial cell detachment and apoptosis, 2) a proinflammatory state manifested by increased IL-8 mRNA expression and P-selectin on the endothelial surface, 3) activation of endothelial NADPH oxidase, 4) an increase in endothelial cell tissue factor that directly correlated with PMNL priming index, and 5) a decrease in endothelial nitric oxide synthase mRNA. Our data support a pathogenic link between PMNL priming and endothelial dysfunction, suggesting that PMNL priming is a potential new nontraditional risk factor for the development of atherosclerosis.

cocultivation; nicotinamide adenine dinucleotide phosphate oxidase; polymorphonuclear leukocyte priming index



Address for reprint requests and other correspondence: S. Sela, Eliachar Research and Microbiology Laboratories, Western Galilee Hospital, Nahariya Medical Center, Nahariya 22100, Israel (e-mail: Shifra.Sela{at}naharia.health.gov.il)




This article has been cited by other articles:


Home page
Eur Heart JHome page
L. Guasti, F. Marino, M. Cosentino, R. C. Maio, E. Rasini, M. Ferrari, L. Castiglioni, C. Klersy, G. Gaudio, A. M. Grandi, et al.
Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up
Eur. Heart J., May 1, 2008; 29(9): 1118 - 1126.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Nakayama, K. Nakayama, W.-J. Zhu, Y. Shirota, H. Terawaki, T. Sato, M. Kohno, and S. Ito
Polymorphonuclear leukocyte injury by methylglyoxal and hydrogen peroxide: a possible pathological role for enhanced oxidative stress in chronic kidney disease
Nephrol. Dial. Transplant., April 28, 2008; (2008) gfn218v1.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
L. Dyugovskaya, A. Polyakov, P. Lavie, and L. Lavie
Delayed Neutrophil Apoptosis in Patients with Sleep Apnea
Am. J. Respir. Crit. Care Med., March 1, 2008; 177(5): 544 - 554.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. Gozal and L. Kheirandish-Gozal
Cardiovascular Morbidity in Obstructive Sleep Apnea: Oxidative Stress, Inflammation, and Much More
Am. J. Respir. Crit. Care Med., February 15, 2008; 177(4): 369 - 375.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Cohen-Mazor, S. Sela, R. Mazor, N. Ilan, I. Vlodavsky, A. L. Rops, J. van der Vlag, H. I. Cohen, and B. Kristal
Are primed polymorphonuclear leukocytes contributors to the high heparanase levels in hemodialysis patients?
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H651 - H658.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Zernecke, I. Bot, Y. Djalali-Talab, E. Shagdarsuren, K. Bidzhekov, S. Meiler, R. Krohn, A. Schober, M. Sperandio, O. Soehnlein, et al.
Protective Role of CXC Receptor 4/CXC Ligand 12 Unveils the Importance of Neutrophils in Atherosclerosis
Circ. Res., February 1, 2008; 102(2): 209 - 217.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.